Indian Drugs
- All
- News
- Videos
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Working With India In Fight Against Drugs, Says US
In a major collaboration with Indian law enforcement in the war on drugs, US authorities have cracked down on online drug-traffickers linked to the country who are allegedly responsible for six overdose deaths in the US.
-
Indian-Origin Businessman Found Guilty In Drink Spike Case In UK
An Indian-origin businessman on trial in London was on Friday found guilty of intentionally spiking the drink of a woman with a dangerous drug at a nightclub two years ago.
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Budget 2026: India's Evidence-Based Holistic Healthcare Ecosystem Gets A Boost, Says Ayush Minister
The Union Budget announcements link health policy with rural livelihoods, export growth, youth employment and entrepreneurship — strengthening Indias emergence as the world capital of evidence-based holistic healthcare, Ayush
-
India Sets Import Price Floor On Key Penicillin Ingredients To Protect Drug Supply
The government has imposed a minimum import price on three key penicillin ingredients for one year, aiming to support domestic manufacturers and secure India's antibiotic supply chain.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Indian Pharmaceutical Body Signs 3 Memorandums To Strengthen Drug Safety And Quality Standards
The Indian Pharmacopoeia Commission has signed memoranda with the Goa State Pharmacy Council, Quality Council of India, and HLL Infra Tech Services to strengthen drug safety, quality assurance and pharmacovigilance.
-
Working With India In Fight Against Drugs, Says US
In a major collaboration with Indian law enforcement in the war on drugs, US authorities have cracked down on online drug-traffickers linked to the country who are allegedly responsible for six overdose deaths in the US.
-
Indian-Origin Businessman Found Guilty In Drink Spike Case In UK
An Indian-origin businessman on trial in London was on Friday found guilty of intentionally spiking the drink of a woman with a dangerous drug at a nightclub two years ago.
-
Budget 2026: Middle Class Set To Gain From Affordable Healthcare, Says Dr Jitendra Singh
Affordable drugs, vaccines and diagnostics, supported by domestic biomanufacturing, would be a major social and economic support, especially for the middle class and vulnerable sections, said Union Minister of State.
-
Budget 2026: India's Evidence-Based Holistic Healthcare Ecosystem Gets A Boost, Says Ayush Minister
The Union Budget announcements link health policy with rural livelihoods, export growth, youth employment and entrepreneurship — strengthening Indias emergence as the world capital of evidence-based holistic healthcare, Ayush
-
India Sets Import Price Floor On Key Penicillin Ingredients To Protect Drug Supply
The government has imposed a minimum import price on three key penicillin ingredients for one year, aiming to support domestic manufacturers and secure India's antibiotic supply chain.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
